These data suggest acceleration of the Rab3 cycle may increase ANP secretion and could potentially be harnessed to increase circulating levels of natriuretic peptides for cardiovascular protection in patients with hypertension and/or heart failure but need to be interpreted with caution. Here, NPPA is linked to Hypertension.